Research Article| Volume 95, ISSUE 1-2, P35-42, March 01, 1999

Download started.


Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August rats


      A phosphodiesterase inhibitor (PDEI), Ibudilast, which has been in wide use for the management of bronchial asthma and cerebrovascular disease in Japan, was tested for its clinical efficacy on experimental autoimmune encephalomyelitis (EAE) in Dark August rats. The severity of acute EAE was significantly ameliorated by prophylactic oral treatment with Ibudilast (10 mg/kg per day) starting on the day of immunization, although it did not modify the course of the disease when it was given after the onset of the first clinical sign of EAE. Histologically, inflammatory cell infiltration in the lumbar spinal cord was significantly reduced in Ibudilast-treated animals as compared to control animals. Ibudilast mildly suppressed MBP-induced proliferation of T cells in regional lymph nodes, the secretion of interferon-γ from T cells activated by MBP in CFA, and the secretion of tumor necrosis factor-α from macrophages. While the in vitro studies did not suggest difference between Ibudilast and other PDEIs such as rolipram, the clinical dose of Ibudilast is ∼200-fold higher than that of rolipram and the effective dose of Ibudilast was relatively close to what has been therapeutically used in patients. Thus, Ibudilast may be a candidate for clinical use for patients with multiple sclerosis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Neuroimmunology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Beavo J.A.
        • Conti M.
        • Heaslip R.J.
        Multiple cyclic nucleotide phosphodiesterases.
        Mol. Pharmacol. 1994; 46: 399-405
        • Duong T.T.
        • Louis J.S.
        • Gilbert J.J.
        • Finkelman F.D.
        • Strejan G.H.
        Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse.
        J. Neuroimmunol. 1992; 36: 105-115
        • Endres S.
        • Fülle H.-J.
        • Sinha B.
        • Stoll D.
        • Dinarello C.A.
        • Gerzer R.
        • Weber P.C.
        Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-α and interleukin-1β by human mononuclear cells.
        Immunology. 1991; 72: 56-60
        • Fabian R.H.
        • Rea H.C.
        Neuronal toxicity by macrophages in mixes brain cell culture is augmented by antineuronal IgG and dependent upon nitric oxide synthesis.
        J. Neuroimmunol. 1993; 44: 95-102
        • Genain C.P.
        • Roberts T.
        • Davis R.L.
        • Nguyen M.H.
        • Uccelli A.
        • Faulds D.
        • Li Y.
        • Hedgpeth J.
        • Hauser S.
        Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.
        Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 3601-3605
        • Greten T.F.
        • Eigler A.
        • Sinha B.
        • Moeller J.
        • Endres S.
        The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediator TNF-α and nitric oxide.
        Int. J. Immunopharmacol. 1995; 17: 605-610
        • Jung S.
        • Zielasek J.
        • Köllner G.
        • Donhauser T.
        • Toyka K.
        • Hartung H.-P.
        Preventive but not therapeutic application of rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
        J. Neuroimmunol. 1996; 68: 1-11
        • Kambayashi T.
        • Jacob C.O.
        • Zhou D.
        • Mazurek N.
        • Fong M.
        • Strassman G.
        Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages.
        J. Immunol. 1995; 155: 4909-4916
        • Kawasaki A.
        • Hoshino K.
        • Osaki R.
        • Mizushima Y.
        • Yano S.
        Effect of Ibudilast: a novel anti-asthmatic agent, on airway hypersensitivity in bronchial asthma.
        J. Asthma. 1992; 29: 245-252
        • Lugnier C.
        • Schini V.B.
        Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
        Biochem. Pharmacol. 1990; 39: 75-84
        • MacMicking J.D.
        • Willenborg D.O.
        • Weidemann M.J.
        • Rockett K.A.
        • Cowden W.D.
        Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells.
        J. Exp. Med. 1992; 176: 303-307
        • Merrill J.E.
        • Kono D.H.
        • Clayton J.
        • Ando D.G.
        • Hinton D.R.
        • Hofman F.M.
        Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10PL mice.
        Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 574-578
        • Merrill J.E.
        • Ignarro L.J.
        • Sherman M.P.
        • Melinek J.
        • Lane T.E.
        Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
        J. Immunol. 1993; 151: 2132-2141
        • Milo R.
        • Panitch H.
        Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein.
        J. Neuroimmunol. 1995; 61: 185-193
        • Munoz E.
        • Zubiaga A.M.
        • Merrow M.
        • Sauter N.P.
        • Huber B.T.
        Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation.
        J. Exp. Med. 1990; 172: 95-103
        • Nataf S.
        • Louboutin J.P.
        • Chabannes D.
        • Feve J.R.
        • Muller J.Y.
        Pentoxifylline inhibits experimental allergic encephalomyelitis.
        Acta. Neurol. Scand. 1993; 88: 97-99
        • Nicholson C.D.
        • Shahid M.
        Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes—their potential utility in the therapy of asthma.
        Pulm. Pharmacol. 1994; 7: 1-17
        • Nicholson C.D.
        • Challiss R.A.J.
        • Shahid M.
        Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
        Trends Pharmacol. 1991; 12: 19-27
        • Ohashi M.
        • Ohkubo H.
        • Kito J.
        • Nishino K.
        A new vasodilator 3-isobutyryl-2-isopropyl-pyrazolol[1,5-a]pyridine (KC-404) has a dual mechanism of action on platelet aggregation.
        Arch. Int. Pharmacodyn. Ther. 1986; 283: 321-334
        • Okuda Y.
        • Sakoda S.
        • Fujimura H.
        • Yanagihara T.
        Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells.
        Immunopharmacology. 1996; 35: 141-148
        • Okuda Y.
        • Sakoda S.
        • Fujimura H.
        • Yanagihara T.
        Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase.
        J. Neuroimmunol. 1998; 81: 201-210
        • Oppenheimer-Marks N.
        • Ziff M.
        Migration of lymphocytes through endothelial cell monolayers: augmentation by interferon-gamma.
        Cell. Immunol. 1988; 114: 307-323
        • Oppenheimer-Marks N.
        • Kavanaugh A.F.
        • Lipsky P.E.
        Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E2.
        J. Immunol. 1994; 152: 5703-5713
        • Pober J.S.
        • Slowik M.R.
        • De Luca L.G.
        • Ritchie A.J.
        Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1.
        J. Immunol. 1993; 150: 5114-5123
        • Raddassi K.
        • Petit J.-F.
        • Lemaire G.
        LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides.
        Cell. Immunol. 1993; 149: 50-64
        • Renno T.
        • Krakowski M.
        • Piccirillo C.
        • Lin J.-y.
        • Owens T.
        TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines.
        J. Immunol. 1995; 154: 944-953
        • Rivero V.E.
        • Maccioni M.
        • Bucher A.E.
        • Roth G.A.
        • Riera C.M.
        Suppression of experimental autoimmune encephalomyelitis (EAE) by intraperitoneal administration of soluble myelin antigens in Wistar rats.
        J. Neuroimmunol. 1997; 72: 3-10
        • Rott O.
        • Cash E.
        • Fleischer B.
        Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1—but not type 2—associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
        Eur. J. Immunol. 1993; 23: 1745-1751
        • Schade F.U.
        • Schudt C.
        The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages.
        Eur. J. Pharmacol. 1993; 230: 9-14
        • Selmaj K.
        • Papierz W.
        • Glabinski A.
        • Kohno T.
        Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor 1.
        J. Neuroimmunol. 1995; 56: 135-141
        • Sinha B.
        • Semmler J.
        • Eisenhut T.
        • Eigler A.
        • Endres S.
        Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.
        Eur. J. Immunol. 1995; 25: 147-153
        • Sommer N.
        • Loschmann P.-A.
        • Northoff G.H.
        • Weller M.
        • Steinbrecher A.
        • Steinbach J.P.
        • Lichtenfels R.
        • Meyermann R.
        • Riethmuller A.
        • Fontana A.
        • Dichgans J.
        • Martin R.
        The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis.
        Nat. Med. 1995; 1: 244-248
        • Souness J.E.
        • Diocee B.K.
        • Martin W.
        • Moodie S.A.
        Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitor to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
        Biochem. J. 1990; 266: 127-132
        • Souness J.E.
        • Scott L.C.
        • Tomkinson A.
        • Giembycz M.A.
        • Raeburn D.
        Inhibition of cyclic nucleotide phosphodiesterase by Ibudilast: comparison with rolipram.
        Br. J. Pharmacol. 1993; 108: 71p
        • Souness J.E.
        • Villami M.E.
        • Scott L.C.
        • Tomkinson A.
        • Giembycz M.A.
        • Raeburn D.
        Possible role of cyclic AMP phosphodiesterases in the action of Ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
        Br. J. Pharmacol. 1994; 111: 1081-1088
        • Sowa G.
        • Przewlocki R.
        cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures.
        Eur. J. Pharmacol. 1994; 266: 125-129
        • Stepaniak J.A.
        • Gould K.E.
        • Sun D.
        • Swanborg R.H.
        A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
        J. Immunol. 1995; 155: 2762-2769
        • Suttorp N.
        • Weber U.
        • Welsch T.
        • Schudt C.
        Role of phosphodiesterases in the regulation of endothelial permeability in vitro.
        J. Clin. Invest. 1993; 91: 1421-1428
        • Tomkinson A.
        • Sharma A.
        • Giembycz M.A.
        • Souness J.E.
        • Raeburn D.
        Effects of Ibudilast on airways smooth muscle contraction in vitro and in vivo; Comparison with rolipram.
        Br. J. Pharmacol. 1993; 108: 73
        • van Oosten B.W.
        • Barkhof F.
        • Truyen L.
        • Boringa J.B.
        • Bertelsmann F.W.
        • von Blomberg B.M.E.
        • Woody J.N.
        • Hartung H.-P.
        • Polman C.H.
        Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.
        Neurology. 1996; 47: 1531-1534
        • Zielasek J.
        • Tausch M.
        • Toyka K.V.
        • Hartung H.-P.
        Production of nitrite by neonatal rat microglial cells/brain macrophages.
        Cell. Immunol. 1992; 141: 111-120